Del Soldato P
Agents Actions. 1984 Feb;14(2):139-42. doi: 10.1007/BF01966633.
Although the factors involved in the induction of gastric pathology have long been studied, the exact roles of the two histamine receptors in this process are still obscure. The aim of this study was to evaluate the consequences of the activation of histamine H1- and/or H2-receptors in the pathogenesis of gastric damage and antagonism of these pathological developments by specific antagonists. The following agents were used: histamine as H1- and H2H2-agonist; 2-pyridylethylamine (PEA) and mepyramine as H1-agonist and antagonist; dimaprit and ranitidine as H2-agonist and antagonist. Intravenous administration of the agonists caused definite gastric damage in rats. Both the antagonists inhibited histamine-induced gastric lesions, but the PEA and dimaprit-induced erosions could be prevented only by giving the specific H1- or H2-antagonist. In conclusion, activation of either H1- or H2-receptors can play a crucial role in the pathogenesis of histamine-induced gastric damage in rats.
尽管长期以来一直在研究诱发胃部病变的相关因素,但两种组胺受体在这一过程中的确切作用仍不清楚。本研究的目的是评估组胺H1和/或H2受体激活在胃损伤发病机制中的后果,以及特定拮抗剂对这些病理发展的拮抗作用。使用了以下药物:组胺作为H1和H2激动剂;2-吡啶乙胺(PEA)和甲氧苄胺作为H1激动剂和拮抗剂;二甲双胍和雷尼替丁作为H2激动剂和拮抗剂。静脉注射激动剂会在大鼠身上造成明确的胃损伤。两种拮抗剂都能抑制组胺引起的胃部病变,但只有给予特定的H1或H2拮抗剂才能预防PEA和二甲双胍引起的糜烂。总之,H1或H2受体的激活在大鼠组胺诱导的胃损伤发病机制中可能起关键作用。